Bwx Technologies Inc SEC Filings

BWX Technologies director reports small derivative award tied to deferred RSUs. A company director filed a Form 4 reporting the acquisition of 5.25 dividend equivalent rights on BWX Technologies common stock on 12/10/2025. These rights accrued on three existing restricted stock unit grants for which the director has elected to defer receipt of the underlying shares. Each restricted stock unit and each dividend equivalent right represents a contingent right to receive one share of BWX Technologies common stock. After this transaction, the director beneficially owned 41.78 dividend equivalent rights related to BWX Technologies common stock, which will be delivered proportionately over time with the associated restricted stock units.

BWX Technologies, Inc. director Leland D. Melvin reported acquiring dividend equivalent rights tied to his existing deferred restricted stock units. On 12/10/2025, he received 11.42 dividend equivalent rights, each representing a contingent right to receive one share of BWXT common stock, matching four restricted stock unit grants for which he has elected to defer share receipt. These rights will be delivered to him proportionately with the related RSUs. The filing shows he now beneficially owns 204.39 dividend equivalent rights on a direct basis, with a stated price of $0 for the derivative securities.

BWX Technologies, Inc. director Kenneth J. Krieg reported an acquisition of dividend equivalent rights tied to his existing equity awards. On 12/10/2025, he received 29.22 dividend equivalent rights associated with nine restricted stock unit (RSU) grants, with each right representing a contingent claim to one share of BWXT common stock at a price of $0 per right. Following this transaction, he beneficially owned 1,392.2 derivative securities directly. The filing notes that Krieg has elected to defer receipt of the RSU shares, and the related dividend equivalent rights will be delivered proportionately when those RSUs are ultimately settled in BWXT common stock.

BWX Technologies, Inc. director James M. Jaska reported a routine equity compensation-related transaction. On 12/10/2025, he acquired 21.82 dividend equivalent rights (DERs) tied to BWXT common stock at a price of $0 per right. Each DER represents a contingent right to receive one share of BWXT common stock.

The filing states these DERs accrued on seven restricted stock unit (RSU) grants for which Jaska has elected to defer receipt of the underlying shares. The DERs will be delivered proportionately with the related RSUs. Following this transaction, he beneficially owned 1,065.53 DERs, held directly.

BWX Technologies, Inc. director reports additional stock-linked rights. On 12/10/2025, a reporting person who serves as a director of BWX Technologies, Inc. (ticker BWXT) acquired 17.69 dividend equivalent rights tied to existing restricted stock unit (RSU) awards. Each RSU and each dividend equivalent right represents a contingent right to receive one share of BWXT common stock, with no cash exercise price.

The director has elected to defer receipt of the shares underlying these RSUs, and the related dividend equivalent rights will be delivered proportionately as the deferred RSUs are settled. Following this transaction, the director beneficially owned 741.34 dividend equivalent rights on a direct basis.

BWX Technologies, Inc. director Jan A. Bertsch reported receiving additional dividend equivalent rights tied to previously granted restricted stock units as of 12/10/2025. The filing shows 32.84 dividend equivalent rights credited at a price of $0, increasing her total derivative securities beneficially owned to 2,175.51, held directly. Each restricted stock unit and dividend equivalent right represents a contingent right to receive one share of BWXT common stock, and, under her deferral election, the dividend equivalent rights will be delivered proportionately with the related restricted stock units.

BWX Technologies reported new equity awards to a senior executive. On December 1, 2025, the company granted its SVP and General Counsel restricted stock units and stock options. The awards include 801 RSUs that vest in three equal annual installments beginning December 1, 2026, and an additional 1,714 RSUs that vest in two equal annual installments beginning the same date. The filing also shows an employee stock option grant for 2,337 shares of common stock with an exercise price of $174.93 per share, vesting in three equal annual installments from December 1, 2026 and expiring on December 1, 2035. These grants are reported as directly owned by the executive.

BWX Technologies (BWXT) filed a Form 3, the initial statement of beneficial ownership for its SVP and General Counsel. The reporting person disclosed no securities beneficially owned (0) and indicated the filing was made by one reporting person. The event date is 11/04/2025. The submission includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact.

BWX Technologies (BWXT) reported insider transactions by President and CEO Rex D. Geveden. On 11/12/2025, he sold a total of 10,000 shares of common stock in multiple open-market trades pursuant to a Rule 10b5-1 trading plan adopted on 8/11/2025.

The reported weighted average prices for each tranche were $195.0825, $196.7407, $197.6916, $198.6728, and $199.3662. Footnotes state sales occurred within price ranges of $194.7200–$195.6100, $196.0200–$197.0100, $197.1350–$198.1300, $198.1700–$199.1250, and $199.1900–$199.8500, respectively. Following these transactions, he beneficially owned 187,594 shares directly.